TABLE 2.

Demographic and Ophthalmic Data for Patients with Cystoid Macular Edema

Patient	Age	Gender	Eye	Diagnosis	Follow-up (months)	Number of Injections	Phakic Statusa	Prior Injectionsa,b	Active Uveitisa	Diabetica,c	Concurrent Topical Treatmenta,b	Concurrent Systemic Treatmenta,b	Prior Vitrectomya
20	17	F	OS	Pars planitis	13	4	Phakic	None	Yes	No	Prednisolone	CSA, MTX	No
21	58	F	OS	Idiopathic panuveitis	1	1	Pseudophakic	None	Yes	No	Prednisolone	Prednisone, MTX	No
22	81	F	OD	Toxoplasmosis	3	1	Aphakic	None	No	No	None	None	No
23	57	F	OD	Fuchs uveitis syndrome	1	1	Pseudophakic	IVTA ×3	Yes	No	MP, ketorolac	None	No
24	68	F	OS	Idiopathic chronic  iridocyclitis/vitreitis	8	2	Pseudophakic	None	Yes	No	Prednisolone,  nepafenac	None	No
25	72	M	OS	Idiopathic retinal  vasculitis	13	1	Pseudophakic	None	Yes	Yes	Loteprednol,  diclofenac	None	Yes
26	44	M	OD	CMVR/immune-recovery  uveitis	10	2	Phakic	STTA ×3	Yes	No	None	None	No
27a	33	M	OD	Pars planitis	16	2	Pseudophakic	None	No	No	Prednisolone,  nepafenac	Mycophenolate	Yes
27b	33	M	OS	Pars planitis	14	2	Pseudophakic	None	Yes	No	Prednisolone,  nepafenac	Mycophenolate	No
28	67	M	OS	Sarcoid panuveitis	9	2	Pseudophakic	STTA ×1	Yes	No	None	None	Yes
29	79	F	OS	Chronic idiopathic  anterior/intermediate  uveitis	13	2	Pseudophakic	None	Yes	No	Nepafenac	MTX	No
30a	83	F	OD	Idiopathic occlusive  vasculitis	20	4	Pseudophakic	None	Yes	No	None	Prednisone	No
30b	83	F	OS	Idiopathic occlusive  vasculitis	20	1	Pseudophakic	None	Yes	No	None	Prednisone	No

CMVR = cytomegalovirus retinitis; CSA = cyclosporine A; IVTA = intravitreal triamcinolone; MP = methylprednisolone; MTX = methotrexate; OD = right eye; OS = left eye; STTA = sub-Tenon triamcinolone.

^aNone of these variables statistically influenced outcomes with respect to visual acuity or macular thickness.

^bLimited to anti-inflammatory therapies.

^cRefers to the presence or absence of diabetes mellitus; no patients had diabetic retinopathy.